Eight Brocades (Ba Duan Jin) for Treating Patients With Fibromyalgia
A Randomized Controlled Trial of Eight Brocades (Ba Duan Jin) to Improve Quality of Life in Patients With Fibromyalgia
1 other identifier
interventional
62
1 country
1
Brief Summary
In this randomized, usual therapy-controlled study, 62 patients with fibromyalgi (FM) were recruited with a ratio of 1:1. Trained and guided by Eight Brocades (EB) certified physicians, participant practiced EB one hour, twice a week for 12 weeks. Evaluation will be based on standard scales of pain, FM symptoms severity, degree of fatigue, depression, sleep quality and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 24, 2015
CompletedFirst Posted
Study publicly available on registry
March 27, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedJanuary 23, 2018
January 1, 2018
1.9 years
March 24, 2015
January 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The change of Visual Analogue Scales for pain (PVAS) from baseline to 12 weeks.
baseline, 4 weeks, 8 weeks, 12 weeks
The change of Fibromyalgia Impact Questionnaire (FIQ) from baseline to 12 weeks
baseline, 4 weeks, 8 weeks, 12 weeks
Secondary Outcomes (5)
The change of the Short Form-36 Health Status Questionnaire (SF-36) from baseline to 12 weeks
baseline, 4 weeks, 8 weeks, 12 weeks
The change of Multidimensional Assessment Fatigue (MAF) from baseline to 12 weeks
baseline, 4 weeks, 8 weeks, 12 weeks
The change of Beck depression inventory (BDI) from baseline to 12 weeks
baseline, 4 weeks, 8 weeks, 12 weeks
The change of Perceived Stress Scale (PSS) from baseline to 12 weeks
baseline, 4 weeks, 8 weeks, 12 weeks
The change of Pittsburgh sleep quality index (PSQI) from baseline to 12 weeks
baseline, 4 weeks, 8 weeks, 12 weeks
Study Arms (2)
EB group
EXPERIMENTALTrained and guided by EB certified physicians, patients in EB group received closely supervised, group-format EB program and practiced EB for one hour, twice weekly for 12 weeks in the Guang'anmen Hospital.
Control group
NO INTERVENTIONThe participants in usual therapy-controlled group will stay on their previous treatment through 12 weeks. As compensation, they will be invited to receive LEB training for 12 weeks after the end of the study.
Interventions
Patients received closely supervised, group-format EB program and practiced EB revised by Chinese Medicine Master Zhi-zheng Lu for one hour, twice weekly for 12 weeksmovements, a review of principles, and breathing techniques in EB. Participants will be asked to practice EB at home for at least 16 minutes each day which is how long it takes to complete an EB exercise, using an instructional Digital Video Disc. The program will be taught by experienced EB masters.
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Fulfills the American College of Rheumatology (ACR) 1990 classification criteria for FM.
- On a stable variety and dosage of pharmacologic for FM ≥4 weeks
You may not qualify if:
- Prior experience with EB or other similar types of Complementary and Alternative Medicine in the past 1 year such as Qi gong, Tai Chi and yoga since these share some of the principles of EB.
- Dementia, cancer, or other serious medical conditions limiting ability to participate in the Eight Brocades or strength training, as determined by the study physicians.
- Any other diagnosed medical condition known to contribute to FM symptomatology that is not under adequate control for the study period such as thyroid disease, inflammatory arthritis, systemic lupus erythematosus, rheumatoid arthritis, myositis, vasculitis or Sjogren's syndrome.
- Positive urine pregnancy test at baseline or planning pregnancy within the study period.
- Reside \>70 miles from the research site.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan Jiao, M.D.,PhD
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate chief physician
Study Record Dates
First Submitted
March 24, 2015
First Posted
March 27, 2015
Study Start
March 1, 2015
Primary Completion
February 1, 2017
Study Completion
August 1, 2017
Last Updated
January 23, 2018
Record last verified: 2018-01